Longitude Venture Partners III, L.P.'s Net Worth
$0
Estimate Recalculated Nov 3, 2024 09:39PM EST
Who is Longitude Venture Partners III, L.P.?
Longitude Venture Partners III, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Inozyme Pharma, Inc., Axonics Modulation Technologies, Inc., Talaris Therapeutics, Inc., Sierra Oncology, Inc., 89bio, Inc., and Molecular Templates, Inc..
SEC CIK
Longitude Venture Partners III, L.P.'s CIK is 0001674099
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +48.06% | 1.35M |
$3.69 | $4,999,950.00 | 4.17M |
Apr 19
| |||
Form 4
|
∞
| 2.82M |
$16.00 |
—
| 2.82M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axonics Modulation Technologies, Inc. (AXNX) Snapshot price: $68.7655
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.93M |
$15.00 |
—
| 2.93M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Talaris Therapeutics, Inc. (TRML) Snapshot price: $16.11
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.22M |
$17.00 |
—
| 3.22M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -98.59% | -2.12M |
—
|
—
| 30.38K |
Apr 27
| |||
Form 4
|
∞
| 175K |
$27.00 | $4,725,000.00 | 175K |
Feb 2
| |||
Form 4
| +33.00% | 487.45K |
$13.20 | $6,434,353.20 | 1.96M |
Jan 25
| |||
Form 4
|
∞
| 1.48M |
—
|
—
| 1.48M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
89bio, Inc. (ETNB) Snapshot price: $8.47
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.45% | -844.06K |
—
|
—
| 1.76M |
Nov 16
| |||
Form 4
| +4.38% | 109.09K |
$27.50 | $2,999,975.00 | 2.6M |
Jul 10
| |||
Form 4
|
∞
| 2.49M |
$16.00 |
—
| 2.49M |
Nov 11 - Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||